ATD (10%), SLE (1–8%), RA (4%); TPO antibodies (36%), TG antibodies (23%), ANA (23%), rheumatoid factor (8%), AQP4 antibodies (5–7%). This evidence concerns the gene TPO and systemic lupus erythematosus.